Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1464 | 2555 | 41.3 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
120 | 23422 | GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//INSULIN LIKE GROWTH FACTOR I |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GROWTH HORMONE DEFICIENCY | Author keyword | 56 | 23% | 8% | 211 |
2 | ADULT GH DEFICIENCY | Author keyword | 34 | 93% | 1% | 13 |
3 | ADULT GROWTH HORMONE DEFICIENCY | Author keyword | 26 | 69% | 1% | 22 |
4 | GROWTH HORMONE & IGF RESEARCH | Journal | 22 | 14% | 6% | 145 |
5 | GROWTH HORMONE REPLACEMENT | Author keyword | 21 | 64% | 1% | 21 |
6 | GROWTH HORMONE DEFICIENCY IN ADULTS | Author keyword | 21 | 90% | 0% | 9 |
7 | GROWTH HORMONE REPLACEMENT THERAPY | Author keyword | 19 | 76% | 1% | 13 |
8 | KIMS MED OUTCOMES | Address | 19 | 71% | 1% | 15 |
9 | GH DEFICIENCY | Author keyword | 15 | 25% | 2% | 53 |
10 | GROWTH HORMONE DEFICIENT ADULTS | Author keyword | 15 | 88% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPOPITUITARY ADULTS | 458 | 80% | 11% | 287 |
2 | GH DEFICIENT ADULTS | 156 | 62% | 6% | 160 |
3 | DEFICIENT ADULTS | 119 | 47% | 7% | 189 |
4 | GH REPLACEMENT THERAPY | 112 | 67% | 4% | 102 |
5 | GH DEFICIENCY | 99 | 34% | 9% | 242 |
6 | RECOMBINANT HUMAN GH | 87 | 60% | 4% | 94 |
7 | CHILDHOOD ONSET | 57 | 30% | 6% | 157 |
8 | GROWTH HORMONE DEFICIENCY | 52 | 20% | 9% | 226 |
9 | HYPOPITUITARY PATIENTS | 50 | 57% | 2% | 59 |
10 | PREMATURE MORTALITY | 49 | 31% | 5% | 131 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GROWTH HORMONE & IGF RESEARCH | 22 | 14% | 6% | 145 |
2 | ENDOCRINOLOGY AND METABOLISM | 3 | 18% | 1% | 14 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects | 2009 | 217 | 237 | 47% |
Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society clinical practice guideline | 2006 | 193 | 150 | 81% |
Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis | 2015 | 2 | 80 | 53% |
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review | 1998 | 512 | 126 | 80% |
Growth hormone, insulin-like growth factors, and the skeleton | 2008 | 255 | 437 | 38% |
Systematic review: The safety and efficacy of growth hormone in the healthy elderly | 2007 | 120 | 57 | 77% |
Cardiovascular Risk in Adult Patients With Growth Hormone (GH) Deficiency and Following Substitution With GH-An Update | 2014 | 9 | 132 | 70% |
Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis | 2012 | 19 | 60 | 88% |
Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity | 2014 | 4 | 75 | 76% |
Growth hormone and bone | 1998 | 461 | 310 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KIMS MED OUTCOMES | 19 | 71% | 0.6% | 15 |
2 | MED M ENDOCRINOL DIABET | 6 | 30% | 0.7% | 17 |
3 | KIGS | 6 | 58% | 0.3% | 7 |
4 | MED ENDOCRINOL DIABET M | 6 | 19% | 1.1% | 27 |
5 | ENDOCRINE CARE | 5 | 47% | 0.3% | 8 |
6 | PITUITARY UNIT | 5 | 18% | 0.9% | 24 |
7 | ACROSTUDY MED OUTCOMES | 4 | 75% | 0.1% | 3 |
8 | KIMS OUTCOMES | 4 | 75% | 0.1% | 3 |
9 | PL HTA | 3 | 100% | 0.1% | 3 |
10 | GRP REHABIL MED | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165999 | PHARMACOL CLIN SECT//HOSP J CANALEJO//PEDIAT RIA PHARMACOL RADIOL ENDOCRINOL |
2 | 0.0000152021 | SALFORD ROYAL HOSP UNIV TRUST//MED 0613B//MED HUMAN LIFE SCI |
3 | 0.0000136354 | IDIOPATHIC SHORT STATURE//SHORT STATURE//GROWTH HORMONE DEFICIENCY |
4 | 0.0000123663 | HYPOPITUITARISM//PITUITARY DYSFUNCTION//POST TRAUMATIC HYPOPITUITARISM |
5 | 0.0000104135 | CC MORFOL FISIOL//SCI POLYMER TECHNOL//MAC25 |
6 | 0.0000092121 | ACROMEGALY//PEGVISOMANT//GROWTH HORMONE RECEPTOR ANTAGONIST |
7 | 0.0000090817 | AMES DWARF//EDISON BIOTECHNOL//AMES DWARF MICE |
8 | 0.0000087066 | 20K HGH//22K HGH//GH ABUSE |
9 | 0.0000079795 | LARON SYNDROME//GROWTH HORMONE RECEPTOR//GROWTH HORMONE INSENSITIVITY |
10 | 0.0000071950 | BIOMED SURG CELL BIOL//MED CHILDRENS CLIN//RHIGF I THERAPY |